Case Report

Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report

Volume: 4 Number: 2 August 30, 2022
EN TR

Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report

Abstract

Changes in blood parameters may occur during the use of psychiatric drugs. In such cases, the general condition of the patient and the blood parameters are closely monitored and the treatment is discontinued or the medication is changed. The purpose of this case report was to be alert to the possibility of side effects such as neutropenia due to antipsychotic drugs and to draw attention to the management of these patients

Keywords

Supporting Institution

yok

Project Number

yok

References

  1. 1. Bonilla MA. Disorders of white blood cells. In Manual of Pediatric Hematology and Oncology, Lanzkowsky ed, 5th edition, Amsterdam, Elsevier, 2011, p:272-320
  2. 2. Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol Clin Exp. 2008; 23(1): 27-41
  3. 3. Uetrecht JP. Reactive metabolites and agranulocytosis. Eur J Haematol Suppl. 1996; 60: 83-88
  4. 4. Brouns R, De Deyn PP. Neurological complications in renal failure : a review. Clin Neurol Neurosurg. 2004; 107 (1): 1-16. doi: 10.1016/j.clineuro.2004.07.012.
  5. 5. Nair P, Lippmann S. Is leukopenia associated with divalproex and/or quetiapine? Can J Psychiatry. 2003; 48: 65-66
  6. 6. Bartels M, van Solinge WW, den Breeijen HJ, Bierings MB, Coffer PJ, Egberts TCG. Valproic acid treatment is associated with altered leukocyte subset development. J Clin Psychopharmacol. 2012; 32: 832–4
  7. 7. Rahman A, Mican LM, Fischer C, Campbell AH. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents. Ann Pharmacother. 2009; 43: 822-830
  8. 8. Petrini M, Azzarà A. Lithium in the treatment of neutropenia. Curr Opin Hematol. 2012; 19(1): 52-7. doi: 10.1097/MOH.0b013e32834da93b

Details

Primary Language

English

Subjects

Emergency Medicine

Journal Section

Case Report

Publication Date

August 30, 2022

Submission Date

August 16, 2022

Acceptance Date

August 22, 2022

Published in Issue

Year 2022 Volume: 4 Number: 2

APA
Mehmetaj, L., Ugur, Y., Taslidere, B., Sonmez, E., & Cander, B. (2022). Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report. Eurasian Journal of Toxicology, 4(2), 57-58. https://doi.org/10.51262/ejtox.1162734
AMA
1.Mehmetaj L, Ugur Y, Taslidere B, Sonmez E, Cander B. Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report. Eurasian J Tox. 2022;4(2):57-58. doi:10.51262/ejtox.1162734
Chicago
Mehmetaj, Liljana, Yasin Ugur, Bahadir Taslidere, Ertan Sonmez, and Basar Cander. 2022. “Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report”. Eurasian Journal of Toxicology 4 (2): 57-58. https://doi.org/10.51262/ejtox.1162734.
EndNote
Mehmetaj L, Ugur Y, Taslidere B, Sonmez E, Cander B (August 1, 2022) Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report. Eurasian Journal of Toxicology 4 2 57–58.
IEEE
[1]L. Mehmetaj, Y. Ugur, B. Taslidere, E. Sonmez, and B. Cander, “Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report”, Eurasian J Tox, vol. 4, no. 2, pp. 57–58, Aug. 2022, doi: 10.51262/ejtox.1162734.
ISNAD
Mehmetaj, Liljana - Ugur, Yasin - Taslidere, Bahadir - Sonmez, Ertan - Cander, Basar. “Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report”. Eurasian Journal of Toxicology 4/2 (August 1, 2022): 57-58. https://doi.org/10.51262/ejtox.1162734.
JAMA
1.Mehmetaj L, Ugur Y, Taslidere B, Sonmez E, Cander B. Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report. Eurasian J Tox. 2022;4:57–58.
MLA
Mehmetaj, Liljana, et al. “Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report”. Eurasian Journal of Toxicology, vol. 4, no. 2, Aug. 2022, pp. 57-58, doi:10.51262/ejtox.1162734.
Vancouver
1.Liljana Mehmetaj, Yasin Ugur, Bahadir Taslidere, Ertan Sonmez, Basar Cander. Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report. Eurasian J Tox. 2022 Aug. 1;4(2):57-8. doi:10.51262/ejtox.1162734